Tata Small Cap Fund

Tata Small Cap Fund's XIRR stands at 23.78% over 3 years and 25.82% over 5 years, beating the category average SIP XIRR of 20.09% and 22.84% respectively, though its 1Y XIRR of 12.89% trails the category's 17.53%. Against the NIFTY SmallCap 250, the fund's alpha has deteriorated recently — negative 7.23% over 1Y and negative 2.89% over 3Y, while longer horizons remain positive (3.89% over 7Y, 3.62% over 10Y). Two consecutive negative calendar years (2025: -11.96%, 2026 YTD: -3.99%) follow strong 2023-24 gains of 34.6% and 32.61%.

Downside capture consistently below 100% across all windows (as low as 74.16% over 10Y-15Y) indicates the fund has historically cushioned small-cap downturns better than the benchmark, though the recent 1Y downside capture of 95.37% shows weaker protection lately. Five drawdown events exceeding 10% confirm meaningful risk, but the current max drawdown of just -0.37% with a 46-day duration and 175-day full recovery suggests the fund is in a stable phase. Calmar ratios between 0.60 and 0.77 across horizons point to moderately satisfactory risk-adjusted returns.

The top 10 holdings account for roughly 35% of NAV across 56 total stocks, indicating reasonable diversification for a small-cap fund. Industrial Products dominates at 17.8% of the portfolio, followed by Chemicals & Petrochemicals at 9.8%, creating meaningful cyclical-industrial tilt. Top positions like Sudarshan Chemical (4.54%), Usha Martin (4.38%), and Kirloskar Pneumatic (4.30%) are individually capped below 5%, limiting single-stock risk.

The fund outpaces category average SIP XIRR in the 3Y, 5Y, and 7Y windows (23.78% vs 20.09%, 25.82% vs 22.84%, 20.64% vs 21.77% respectively — though the 7Y figure slightly lags). Consistency is mixed: strong long-term alpha over 7Y-15Y windows coexists with negative alpha in the last 1-3 years, suggesting recent underperformance relative to its own long-term record. A low and declining beta (0.79 over longer windows) reflects a defensive style within the small-cap category.

This fund suits investors with a high risk tolerance and a horizon of at least 5-7 years, given small-cap volatility and the current drawdown-heavy phase. It is appropriate as a satellite allocation, ideally through SIPs to smooth entry points during the ongoing weak stretch. Investors seeking recent outperformance versus category peers should note the trailing 1Y and 3Y XIRR shortfalls and monitor whether long-term alpha re-emerges.

• 5Y SIP XIRR of 25.82% clearly exceeds the category average of 22.84%, with 3Y also ahead (23.78% vs 20.09%)
• Long-term downside capture below 100% (74-80% over 7Y-15Y windows) and positive alpha of 3.62-3.89% over 7Y-10Y show strong historical risk management
• Well-diversified 56-stock portfolio with no single holding above 4.54% of NAV

• Recent alpha is negative — -7.23% over 1Y and -2.89% over 3Y versus the NIFTY SmallCap 250 — with the 1Y fund CAGR of -10.42% badly lagging the benchmark's -3.72%
• Two consecutive negative calendar years (-11.96% in 2025, -3.99% in 2026) and a 17.8% industrial-products tilt expose investors to a cyclical, underperforming phase